000403.SZ
派林生物
SZSE · Healthcare · C 制造业 · CN
CNY 10.26
−3.48%Margins
Gross margin
39.7%
EBITDA margin
25.9%
EBIT margin
17.3%
Net margin
13.6%
FCF margin
-20.9%
4.4%
Return on equity
3.8%
Return on assets
5.1%
Return on invested capital
0.28x
Asset turnover
-CNY 272.0M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026